Renz H, Enssle K, Lauffer L, Kurrle R, Gelfand E W
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colo 80206.
Int Arch Allergy Immunol. 1995 Jan;106(1):46-54. doi: 10.1159/000236889.
In this study, the effect of soluble IL-4 receptors (sIL-4R) on murine allergen-induced IgE and IgG1 production was examined. Lymphocytes from mice sensitized to the allergens ragweed (RW) or ovalbumin (OVA) in vivo were restimulated in vitro with the sensitizing allergen in the presence of either a soluble murine sIL-4R, a dimeric sIL-4R Ig fusion protein (sIL-4R/Fc), or anti-IL-4 antibody in 14-day cultures. Both monomeric and dimeric sIL-4R inhibited polyclonal IgE (approximately 70%) and IgG1 (approximately 35%) production in a dose-dependent fashion, similar to that observed in the presence of the anti-IL-4 antibody. Allergen-specific IgE and IgG1 were inhibited to a greater degree. Addition of sIL-4R was most effective when present in the culture during the first 3 days and added not later than day 6. In kinetic experiments, we distinguished ongoing IgE production from precommitted B cells versus newly induced IgE synthesis and found that newly induced IgE production was the major target of the sIL-4Rs. These data demonstrate the efficacy of sIL-4R in inhibiting the early stages of the IgE B-cell maturation pathway and indicate the potential of sIL-4R for the inhibition of IgE production in vivo.
在本研究中,检测了可溶性白细胞介素-4受体(sIL-4R)对小鼠变应原诱导的IgE和IgG1产生的影响。将在体内对豚草(RW)或卵清蛋白(OVA)变应原致敏的小鼠淋巴细胞,在体外于14天培养期内,在可溶性小鼠sIL-4R、二聚体sIL-4R Ig融合蛋白(sIL-4R/Fc)或抗白细胞介素-4抗体存在的情况下,用致敏变应原再次刺激。单体和二聚体sIL-4R均以剂量依赖方式抑制多克隆IgE(约70%)和IgG1(约35%)的产生,类似于在抗白细胞介素-4抗体存在时所观察到的情况。变应原特异性IgE和IgG1受到的抑制程度更大。当在培养的前3天存在且不迟于第6天添加sIL-4R时效果最佳。在动力学实验中,我们区分了来自预先致敏B细胞的持续IgE产生与新诱导的IgE合成,发现新诱导的IgE产生是sIL-4R的主要作用靶点。这些数据证明了sIL-4R在抑制IgE B细胞成熟途径早期阶段的有效性,并表明sIL-4R在体内抑制IgE产生的潜力。